Darunavir Is a Good Third-Line Antiretroviral Agent for HIV Type 1-Infected Patients Failing Second-Line Protease Inhibitor-Based Regimens in South India

Eleven protease mutations have been associated with reduced susceptibility to darunavir. In this study of 87 HIV-1-infected patients experiencing virological failure to second-line regimens containing protease inhibitors boosted with ritonavir (viral load >1,000 HIV RNA copies/ml), we observed a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Saravanan, Shanmugam, Madhavan, Vidya, Balakrishnan, Pachamuthu, Smith, Davey M., Solomon, Sunil Suhas, Sivamalar, Sathasivam, Poongulali, Selvamuthu, Kumarasamy, Nagalingeswaran, Schooley, Robert T., Solomon, Suniti, Kantor, Rami
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2013
Assuntos:
Sequence Notes
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3581023/
https://ncbi.nlm.nih.gov/pubmed/23045961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/aid.2011.0334
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados